Annual Shareholders Equity
-$111.20 K
+$8.86 M+98.76%
December 1, 2023
Summary
- As of February 8, 2025, CYTO annual stockholders equity is -$111.20 thousand, with the most recent change of +$8.86 million (+98.76%) on December 1, 2023.
- During the last 3 years, CYTO annual shareholders equity has fallen by -$19.31 million (-100.58%).
- CYTO annual shareholders equity is now -100.21% below its all-time high of $53.88 million, reached on December 31, 2014.
Performance
CYTO Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$6.32 M
+$6.43 M+5781.92%
June 1, 2024
Summary
- As of February 8, 2025, CYTO quarterly stockholders equity is $6.32 million, with the most recent change of +$6.43 million (+5781.92%) on June 1, 2024.
- Over the past year, CYTO quarterly shareholders equity has increased by +$8.35 million (+411.40%).
- CYTO quarterly shareholders equity is now -89.63% below its all-time high of $60.94 million, reached on September 30, 2014.
Performance
CYTO Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
CYTO Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +98.8% | +411.4% |
| 3 y3 years | -100.6% | +170.4% |
| 5 y5 years | -103.0% | +170.4% |
CYTO Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -100.8% | +98.8% | -55.7% | +170.4% |
| 5 y | 5-year | -100.6% | +98.8% | -71.0% | +170.4% |
| alltime | all time | -100.2% | +98.8% | -89.6% | +170.4% |
Altamira Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $6.32 M(-5781.9%) |
| Dec 2023 | -$111.20 K(-98.8%) | -$111.20 K(-94.5%) |
| Jun 2023 | - | -$2.03 M(-77.4%) |
| Dec 2022 | -$8.97 M(-162.9%) | -$8.97 M(-211.5%) |
| Jun 2022 | - | $8.04 M(-43.6%) |
| Dec 2021 | $14.26 M(-25.7%) | $14.26 M(-34.6%) |
| Jun 2021 | - | $21.81 M(+13.6%) |
| Dec 2020 | $19.19 M(+208.1%) | $19.19 M(+307.6%) |
| Jun 2020 | - | $4.71 M(-24.4%) |
| Dec 2019 | $6.23 M(+68.1%) | $6.23 M(-32.0%) |
| Jun 2019 | - | $9.16 M(+147.2%) |
| Dec 2018 | $3.71 M(-267.0%) | $3.71 M(-590.9%) |
| Sep 2018 | - | -$755.10 K(-78.8%) |
| Jun 2018 | - | -$3.56 M(+139.9%) |
| Mar 2018 | - | -$1.48 M(-33.2%) |
| Dec 2017 | -$2.22 M | -$2.22 M(+352.7%) |
| Sep 2017 | - | -$490.30 K(-108.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | $5.59 M(-47.0%) |
| Mar 2017 | - | $10.55 M(-24.0%) |
| Dec 2016 | $13.88 M(-69.3%) | $13.88 M(-30.6%) |
| Sep 2016 | - | $20.01 M(-27.6%) |
| Jun 2016 | - | $27.65 M(-25.6%) |
| Mar 2016 | - | $37.19 M(-17.8%) |
| Dec 2015 | $45.27 M(-16.0%) | $45.27 M(-12.0%) |
| Sep 2015 | - | $51.42 M(-13.6%) |
| Jun 2015 | - | $59.50 M(+27.7%) |
| Mar 2015 | - | $46.59 M(-13.5%) |
| Dec 2014 | $53.88 M(+22.5%) | $53.88 M(-11.6%) |
| Sep 2014 | - | $60.94 M(+371.0%) |
| Jun 2014 | - | $12.94 M(-32.0%) |
| Mar 2014 | - | $19.03 M(-56.7%) |
| Dec 2013 | $43.98 M(<-9900.0%) | $43.98 M |
| Dec 2012 | -$267.30 K(-151.9%) | - |
| Dec 2011 | $515.00 K | - |
FAQ
- What is Altamira Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Altamira Therapeutics?
- What is Altamira Therapeutics annual shareholders equity year-on-year change?
- What is Altamira Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Altamira Therapeutics?
- What is Altamira Therapeutics quarterly shareholders equity year-on-year change?
What is Altamira Therapeutics annual stockholders equity?
The current annual shareholders equity of CYTO is -$111.20 K
What is the all time high annual shareholders equity for Altamira Therapeutics?
Altamira Therapeutics all-time high annual stockholders equity is $53.88 M
What is Altamira Therapeutics annual shareholders equity year-on-year change?
Over the past year, CYTO annual stockholders equity has changed by +$8.86 M (+98.76%)
What is Altamira Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of CYTO is $6.32 M
What is the all time high quarterly shareholders equity for Altamira Therapeutics?
Altamira Therapeutics all-time high quarterly stockholders equity is $60.94 M
What is Altamira Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, CYTO quarterly stockholders equity has changed by +$8.35 M (+411.40%)